© MorphoSys INDUSTRY Biopharma GENEDATA CUSTOMER SINCE 2011 ABOUT MORPHOSYS MorphoSys, a pioneer in antibody-based therapies, uses its proprietary technology platforms with partners including Bayer, Merck, Boehringer Ingelheim, Novartis, Janssen Pfizer, Daiichi Sankyo, and Roche to develop innovative therapies. KEY CHALLENGES Increase R&D efficiency and throughput in a quickly growing organization. RESULTS Up to more than 50% efficiency gains, enabling a significant scale-up of MorphoSys’ R&D operations. GENEDATA SOLUTION Biotherapeutic Discovery Background & Challenges MorphoSys is a late-stage biopharmaceutical company devoted to the development of innovative and differentiated therapies for patients suffering from serious diseases. Based on its proprietary technology pl

Join for free to read